SCHEMBL7652121

SCHEMBL7652121

CC(C)N(C(C)C)S(=O)(=O)c1ccc(NC(=O)C(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.60
KMT2A Q03164 7/20 0.57
MEN1 O00255 6/20 0.57
S1PR3 Q99500 1/20 0.56
ALDH1A1 P00352 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.52
MAPT P10636 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
SCN1A P35498 1/20 0.51
SCN4A P35499 1/20 0.51
SCN5A Q14524 1/20 0.51
SCN9A Q15858 1/20 0.51
SCN2A Q99250 1/20 0.51
SCN3A Q9NY46 1/20 0.51
SCN8A Q9UQD0 1/20 0.51
SCN10A Q9Y5Y9 1/20 0.51
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
USP2 O75604 1/20 0.49
ESR1 P03372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1593422 0.87 MEN1 (0.74) POLBKMT2AMEN1S1PR3ALDH1A1
SCHEMBL1593502 0.84 ALDH1A1 (0.76) POLBKMT2AMEN1S1PR3ALDH1A1
SCHEMBL6699009 0.81 POLB (0.69) POLBKMT2AMEN1S1PR3ALDH1A1
SCHEMBL7651771 0.81 ALDH1A1 (0.61) POLBKMT2AMEN1S1PR3ALDH1A1
SCHEMBL1593930 0.78 ALDH1A1 (0.67) POLBKMT2AMEN1ALDH1A1MAPT
SCHEMBL7657605 0.77 POLB (0.51) POLBKMT2AMEN1S1PR3ALDH1A1
SCHEMBL1383257 0.77 POLB (1.00) POLBKMT2AMEN1S1PR3L3MBTL1
SCHEMBL7651873 0.74 KMT2A (0.69) POLBKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL7649651 0.74 ALDH1A1 (0.65) POLBKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL7651042 0.74 ALDH1A1 (0.66) POLBKMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed